PMID- 29138698 OWN - NLM STAT- MEDLINE DCOM- 20180713 LR - 20181202 IS - 1687-5443 (Electronic) IS - 2090-5904 (Print) IS - 1687-5443 (Linking) VI - 2017 DP - 2017 TI - Soluble Epoxide Hydrolase Inhibitor and 14,15-Epoxyeicosatrienoic Acid-Facilitated Long-Term Potentiation through cAMP and CaMKII in the Hippocampus. PG - 3467805 LID - 10.1155/2017/3467805 [doi] LID - 3467805 AB - Epoxyeicosatrienoic acids (EETs) are derived from arachidonic acid and metabolized by soluble epoxide hydrolase (sEH). The role of EETs in synaptic function in the central nervous system is still largely unknown. We found that pharmacological inhibition of sEH to stabilize endogenous EETs and exogenous 14,15-EET significantly increased the field excitatory postsynaptic potential (fEPSP) response in the CA1 area of the hippocampus, while additionally enhancing high-frequency stimulation- (HFS-) induced long-term potentiation (LTP) and forskolin- (FSK-) induced LTP. sEH inhibitor (sEHI) N-[1-(oxopropyl)-4-piperidinyl]-N'-[4-(trifluoromethoxy) phenyl)-urea (TPPU) and exogenous 14,15-EET increased HFS-LTP, which could be blocked by an N-methyl-D-aspartate (NMDA) receptor subunit NR2B antagonist. TPPU- or 14,15-EET-facilitated FSK-mediated LTP can be potentiated by an A1 adenosine receptor antagonist and a phosphodiesterase inhibitor, but is prevented by a cAMP-dependent protein kinase (PKA) inhibitor. sEHI and 14,15-EET upregulated the activation of extracellular signal-regulated kinases (ERKs) and Ca2+/calmodulin- (CaM-) dependent protein kinase II (CaMKII). Phosphorylation of synaptic receptors NR2B and alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor subunit GluR1 was increased by TPPU and 14,15-EET administration. These results indicated that EETs increased NMDAR- and FSK-mediated synaptic potentiation via the AC-cAMP-PKA signaling cascade and upregulated the ERKs and CaMKII, resulting in increased phosphorylation of NR2B and GluR1 in the hippocampus. FAU - Wu, Han-Fang AU - Wu HF AD - Department and Institute of Physiology, School of Medicine, National Yang-Ming University, Taipei, Taiwan. FAU - Chen, Yi-Ju AU - Chen YJ AD - Department and Institute of Physiology, School of Medicine, National Yang-Ming University, Taipei, Taiwan. FAU - Wu, Su-Zhen AU - Wu SZ AD - Department of Anesthesiology, Chi-Mei Medical Center, Tainan, Taiwan. FAU - Lee, Chi-Wei AU - Lee CW AD - Department and Institute of Physiology, School of Medicine, National Yang-Ming University, Taipei, Taiwan. FAU - Chen, I-Tuan AU - Chen IT AD - Department and Institute of Physiology, School of Medicine, National Yang-Ming University, Taipei, Taiwan. FAU - Lee, Yi-Chao AU - Lee YC AD - Graduate Institute of Neural Regenerative Medicine, College of Medical Science and Technology, Taipei Medical University, Taipei, Taiwan. FAU - Huang, Chi-Chen AU - Huang CC AD - Graduate Institute of Neural Regenerative Medicine, College of Medical Science and Technology, Taipei Medical University, Taipei, Taiwan. FAU - Hsing, Chung-Hsi AU - Hsing CH AUID- ORCID: 0000-0002-6091-5371 AD - Department of Anesthesiology, Chi-Mei Medical Center, Tainan, Taiwan. FAU - Tang, Chih-Wei AU - Tang CW AD - Department of Neurology, Far Eastern Memorial Hospital, New Taipei City, Taiwan. AD - Institute of Brain Science, National Yang-Ming University, Taipei, Taiwan. FAU - Lin, Hui-Ching AU - Lin HC AUID- ORCID: 0000-0002-1639-9293 AD - Department and Institute of Physiology, School of Medicine, National Yang-Ming University, Taipei, Taiwan. AD - Graduate Institute of Neural Regenerative Medicine, College of Medical Science and Technology, Taipei Medical University, Taipei, Taiwan. AD - Brain Research Center, National Yang-Ming University, Taipei, Taiwan. LA - eng PT - Journal Article DEP - 20170824 PL - United States TA - Neural Plast JT - Neural plasticity JID - 100883417 RN - 0 (Receptors, AMPA) RN - 0 (Receptors, N-Methyl-D-Aspartate) RN - 81276-03-1 (14,15-epoxy-5,8,11-eicosatrienoic acid) RN - E0399OZS9N (Cyclic AMP) RN - EC 2.7.11.17 (Calcium-Calmodulin-Dependent Protein Kinase Type 2) RN - EC 3.3.2.- (Epoxide Hydrolases) RN - EC 3.3.2.10 (Ephx2 protein, mouse) RN - FC398RK06S (8,11,14-Eicosatrienoic Acid) SB - IM MH - 8,11,14-Eicosatrienoic Acid/administration & dosage/*analogs & derivatives MH - Animals MH - Calcium-Calmodulin-Dependent Protein Kinase Type 2/*metabolism MH - Cyclic AMP/*metabolism MH - Epoxide Hydrolases/antagonists & inhibitors/*metabolism MH - Hippocampus/drug effects/*metabolism MH - *Long-Term Potentiation/drug effects MH - Mice, Inbred C57BL MH - Neurons/drug effects/metabolism MH - Receptors, AMPA/metabolism MH - Receptors, N-Methyl-D-Aspartate/antagonists & inhibitors/metabolism MH - Signal Transduction PMC - PMC5613711 EDAT- 2017/11/16 06:00 MHDA- 2018/07/14 06:00 PMCR- 2017/08/24 CRDT- 2017/11/16 06:00 PHST- 2017/03/17 00:00 [received] PHST- 2017/07/03 00:00 [revised] PHST- 2017/07/27 00:00 [accepted] PHST- 2017/11/16 06:00 [entrez] PHST- 2017/11/16 06:00 [pubmed] PHST- 2018/07/14 06:00 [medline] PHST- 2017/08/24 00:00 [pmc-release] AID - 10.1155/2017/3467805 [doi] PST - ppublish SO - Neural Plast. 2017;2017:3467805. doi: 10.1155/2017/3467805. Epub 2017 Aug 24.